Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) Stock Competitors & Peer Comparison
See ILMNV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ILMNV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ILMNV | $107.00 | +1.66% | 17B | N/A | N/A | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.73% |
| TMO | $574.03 | -0.05% | 213.3B | 24.78 | $23.16 | +0.31% |
| DHR | $197.50 | +1.29% | 138.9B | 24.75 | $7.98 | +0.73% |
| IDXX | $567.84 | +1.57% | 44.8B | 41.81 | $13.58 | N/A |
| A | $139.80 | +1.03% | 39.5B | 24.06 | $5.81 | +0.72% |
| NTRA | $270.36 | +0.97% | 38.7B | -170.04 | -$1.59 | N/A |
| IQV | $233.36 | -0.71% | 38.4B | 19.24 | $12.13 | N/A |
| ILMN | $198.16 | -3.38% | 30B | 39.40 | $5.03 | N/A |
| MTD | $1,445.00 | +2.03% | 29.2B | 33.21 | $43.51 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
ILMNV vs DHR-PB Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, ILMNV's ROE is N/A, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to DHR-PB. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
ILMNV vs TMO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, TMO has a market cap of 213.3B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while TMO trades at $574.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas TMO's P/E ratio is 24.78. In terms of profitability, ILMNV's ROE is N/A, compared to TMO's ROE of +0.13%. Regarding short-term risk, ILMNV is less volatile compared to TMO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
ILMNV vs DHR Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DHR has a market cap of 138.9B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DHR trades at $197.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DHR's P/E ratio is 24.75. In terms of profitability, ILMNV's ROE is N/A, compared to DHR's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DHR's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
ILMNV vs IDXX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, IDXX has a market cap of 44.8B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while IDXX trades at $567.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas IDXX's P/E ratio is 41.81. In terms of profitability, ILMNV's ROE is N/A, compared to IDXX's ROE of +0.71%. Regarding short-term risk, ILMNV is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
ILMNV vs A Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, A has a market cap of 39.5B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while A trades at $139.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas A's P/E ratio is 24.06. In terms of profitability, ILMNV's ROE is N/A, compared to A's ROE of +0.21%. Regarding short-term risk, ILMNV is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check A's competition here
Natera, Inc. (NASDAQ: NTRA)
ILMNV vs NTRA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NTRA has a market cap of 38.7B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NTRA trades at $270.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NTRA's P/E ratio is -170.04. In terms of profitability, ILMNV's ROE is N/A, compared to NTRA's ROE of -0.15%. Regarding short-term risk, ILMNV is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NTRA's competition here
IQVIA Holdings Inc. (NYSE: IQV)
ILMNV vs IQV Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, IQV has a market cap of 38.4B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while IQV trades at $233.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas IQV's P/E ratio is 19.24. In terms of profitability, ILMNV's ROE is N/A, compared to IQV's ROE of +0.22%. Regarding short-term risk, ILMNV is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check IQV's competition here
Illumina, Inc. (NASDAQ: ILMN)
ILMNV vs ILMN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ILMN has a market cap of 30B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ILMN trades at $198.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ILMN's P/E ratio is 39.40. In terms of profitability, ILMNV's ROE is N/A, compared to ILMN's ROE of +0.31%. Regarding short-term risk, ILMNV is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
ILMNV vs MTD Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MTD has a market cap of 29.2B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MTD trades at $1,445.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MTD's P/E ratio is 33.21. In terms of profitability, ILMNV's ROE is N/A, compared to MTD's ROE of -12.00%. Regarding short-term risk, ILMNV is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MTD's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
ILMNV vs DGX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DGX has a market cap of 25.6B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DGX trades at $231.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DGX's P/E ratio is 22.88. In terms of profitability, ILMNV's ROE is N/A, compared to DGX's ROE of +0.14%. Regarding short-term risk, ILMNV is less volatile compared to DGX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
ILMNV vs LH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, LH has a market cap of 25.2B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while LH trades at $307.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas LH's P/E ratio is 18.26. In terms of profitability, ILMNV's ROE is N/A, compared to LH's ROE of +0.12%. Regarding short-term risk, ILMNV is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check LH's competition here
Waters Corporation (NYSE: WAT)
ILMNV vs WAT Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, WAT has a market cap of 24.4B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while WAT trades at $374.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas WAT's P/E ratio is 27.61. In terms of profitability, ILMNV's ROE is N/A, compared to WAT's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check WAT's competition here
Guardant Health, Inc. (NASDAQ: GH)
ILMNV vs GH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, GH has a market cap of 21.3B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while GH trades at $158.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas GH's P/E ratio is -61.56. In terms of profitability, ILMNV's ROE is N/A, compared to GH's ROE of +2.11%. Regarding short-term risk, ILMNV is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
ILMNV vs EXAS Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas EXAS's P/E ratio is -95.37. In terms of profitability, ILMNV's ROE is N/A, compared to EXAS's ROE of -0.09%. Regarding short-term risk, ILMNV is similarly volatile compared to EXAS. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
ILMNV vs MEDP Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MEDP has a market cap of 16B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MEDP trades at $573.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MEDP's P/E ratio is 36.03. In terms of profitability, ILMNV's ROE is N/A, compared to MEDP's ROE of +1.10%. Regarding short-term risk, ILMNV is less volatile compared to MEDP. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MEDP's competition here
PerkinElmer, Inc. (NYSE: PKI)
ILMNV vs PKI Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PKI's P/E ratio is 41.45. In terms of profitability, ILMNV's ROE is N/A, compared to PKI's ROE of +0.03%. Regarding short-term risk, ILMNV is less volatile compared to PKI. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check PKI's competition here
Revvity, Inc. (NYSE: RVTY)
ILMNV vs RVTY Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, RVTY has a market cap of 12.9B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while RVTY trades at $115.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas RVTY's P/E ratio is 22.51. In terms of profitability, ILMNV's ROE is N/A, compared to RVTY's ROE of +0.03%. Regarding short-term risk, ILMNV is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check RVTY's competition here
ICON Public Limited Company (NASDAQ: ICLR)
ILMNV vs ICLR Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ICLR has a market cap of 12.1B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ICLR trades at $158.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ICLR's P/E ratio is 12.92. In terms of profitability, ILMNV's ROE is N/A, compared to ICLR's ROE of +0.04%. Regarding short-term risk, ILMNV is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ICLR's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
ILMNV vs CRL Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CRL has a market cap of 11.1B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CRL trades at $230.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CRL's P/E ratio is 23.09. In terms of profitability, ILMNV's ROE is N/A, compared to CRL's ROE of -0.06%. Regarding short-term risk, ILMNV is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CRL's competition here
Qiagen N.V. (NYSE: QGEN)
ILMNV vs QGEN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, QGEN has a market cap of 8.7B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while QGEN trades at $42.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas QGEN's P/E ratio is 17.63. In terms of profitability, ILMNV's ROE is N/A, compared to QGEN's ROE of +0.11%. Regarding short-term risk, ILMNV is less volatile compared to QGEN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check QGEN's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
ILMNV vs BLLN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BLLN has a market cap of 6.3B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BLLN trades at $137.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BLLN's P/E ratio is 249.67. In terms of profitability, ILMNV's ROE is N/A, compared to BLLN's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BLLN's competition here
Twist Bioscience Corporation (NASDAQ: TWST)
ILMNV vs TWST Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, TWST has a market cap of 6.3B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while TWST trades at $101.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas TWST's P/E ratio is -47.45. In terms of profitability, ILMNV's ROE is N/A, compared to TWST's ROE of -0.30%. Regarding short-term risk, ILMNV is less volatile compared to TWST. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check TWST's competition here
RadNet, Inc. (NASDAQ: RDNT)
ILMNV vs RDNT Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, RDNT has a market cap of 5.3B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while RDNT trades at $66.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas RDNT's P/E ratio is 145.22. In terms of profitability, ILMNV's ROE is N/A, compared to RDNT's ROE of -0.01%. Regarding short-term risk, ILMNV is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
ILMNV vs SHC Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, SHC has a market cap of 5.1B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while SHC trades at $17.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas SHC's P/E ratio is 19.99. In terms of profitability, ILMNV's ROE is N/A, compared to SHC's ROE of +0.21%. Regarding short-term risk, ILMNV is less volatile compared to SHC. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
ILMNV vs SYNH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas SYNH's P/E ratio is 61.40. In terms of profitability, ILMNV's ROE is N/A, compared to SYNH's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to SYNH. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
ILMNV vs VCYT Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, VCYT has a market cap of 3.6B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while VCYT trades at $44.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas VCYT's P/E ratio is 22.43. In terms of profitability, ILMNV's ROE is N/A, compared to VCYT's ROE of +0.09%. Regarding short-term risk, ILMNV is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check VCYT's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
ILMNV vs OLK Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas OLK's P/E ratio is -96.59. In terms of profitability, ILMNV's ROE is N/A, compared to OLK's ROE of -0.07%. Regarding short-term risk, ILMNV is less volatile compared to OLK. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check OLK's competition here
Neogen Corporation (NASDAQ: NEOG)
ILMNV vs NEOG Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NEOG trades at $11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NEOG's P/E ratio is 42.50. In terms of profitability, ILMNV's ROE is N/A, compared to NEOG's ROE of -0.00%. Regarding short-term risk, ILMNV is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NEOG's competition here
CareDx, Inc (NASDAQ: CDNA)
ILMNV vs CDNA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CDNA has a market cap of 2.5B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CDNA trades at $47.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CDNA's P/E ratio is 56.96. In terms of profitability, ILMNV's ROE is N/A, compared to CDNA's ROE of +0.33%. Regarding short-term risk, ILMNV is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
ILMNV vs PSNL Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PSNL has a market cap of 1.4B. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PSNL trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PSNL's P/E ratio is -12.94. In terms of profitability, ILMNV's ROE is N/A, compared to PSNL's ROE of -0.44%. Regarding short-term risk, ILMNV is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check PSNL's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
ILMNV vs CSTL Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CSTL has a market cap of 928.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CSTL trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CSTL's P/E ratio is -69.07. In terms of profitability, ILMNV's ROE is N/A, compared to CSTL's ROE of -0.04%. Regarding short-term risk, ILMNV is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
ILMNV vs GRALV Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas GRALV's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to GRALV's ROE of N/A. Regarding short-term risk, ILMNV is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check GRALV's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
ILMNV vs FLGT Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, FLGT has a market cap of 500.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while FLGT trades at $17.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas FLGT's P/E ratio is 1761.00. In terms of profitability, ILMNV's ROE is N/A, compared to FLGT's ROE of -0.08%. Regarding short-term risk, ILMNV is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check FLGT's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
ILMNV vs NEO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NEO has a market cap of 407M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NEO trades at $15.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NEO's P/E ratio is 121.85. In terms of profitability, ILMNV's ROE is N/A, compared to NEO's ROE of -0.06%. Regarding short-term risk, ILMNV is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NEO's competition here
Global Cord Blood Corporation (NYSE: CO)
ILMNV vs CO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CO's P/E ratio is 5.06. In terms of profitability, ILMNV's ROE is N/A, compared to CO's ROE of +0.11%. Regarding short-term risk, ILMNV is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CO's competition here
Prenetics Global Limited (NASDAQ: PRENW)
ILMNV vs PRENW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PRENW has a market cap of 360.8M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PRENW's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to PRENW's ROE of -0.47%. Regarding short-term risk, ILMNV is similarly volatile compared to PRENW. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check PRENW's competition here
Prenetics Global Limited (NASDAQ: PRE)
ILMNV vs PRE Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PRE has a market cap of 314.8M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PRE trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PRE's P/E ratio is -8.99. In terms of profitability, ILMNV's ROE is N/A, compared to PRE's ROE of -0.47%. Regarding short-term risk, ILMNV is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check PRE's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
ILMNV vs FLDM Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas FLDM's P/E ratio is -4.74. In terms of profitability, ILMNV's ROE is N/A, compared to FLDM's ROE of +0.17%. Regarding short-term risk, ILMNV is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check FLDM's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
ILMNV vs MYGN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MYGN has a market cap of 285.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MYGN trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MYGN's P/E ratio is -23.23. In terms of profitability, ILMNV's ROE is N/A, compared to MYGN's ROE of -0.33%. Regarding short-term risk, ILMNV is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MYGN's competition here
Trinity Biotech plc (NASDAQ: TRIB)
ILMNV vs TRIB Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, TRIB has a market cap of 225.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while TRIB trades at $11.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas TRIB's P/E ratio is -2.89. In terms of profitability, ILMNV's ROE is N/A, compared to TRIB's ROE of +0.68%. Regarding short-term risk, ILMNV is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check TRIB's competition here
Biodesix, Inc. (NASDAQ: BDSX)
ILMNV vs BDSX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BDSX has a market cap of 179.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BDSX trades at $22.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BDSX's P/E ratio is -5.43. In terms of profitability, ILMNV's ROE is N/A, compared to BDSX's ROE of -21.01%. Regarding short-term risk, ILMNV is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BDSX's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
ILMNV vs IMDX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, IMDX has a market cap of 162.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while IMDX trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas IMDX's P/E ratio is -4.23. In terms of profitability, ILMNV's ROE is N/A, compared to IMDX's ROE of +3.81%. Regarding short-term risk, ILMNV is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
ILMNV vs GTH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas GTH's P/E ratio is -1.11. In terms of profitability, ILMNV's ROE is N/A, compared to GTH's ROE of -1.01%. Regarding short-term risk, ILMNV is less volatile compared to GTH. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check GTH's competition here
Exagen Inc. (NASDAQ: XGN)
ILMNV vs XGN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, XGN has a market cap of 113.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while XGN trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas XGN's P/E ratio is -6.32. In terms of profitability, ILMNV's ROE is N/A, compared to XGN's ROE of -1.14%. Regarding short-term risk, ILMNV is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check XGN's competition here
Genetic Technologies Limited (NASDAQ: GENE)
ILMNV vs GENE Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas GENE's P/E ratio is -38.25. In terms of profitability, ILMNV's ROE is N/A, compared to GENE's ROE of -1.85%. Regarding short-term risk, ILMNV is similarly volatile compared to GENE. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check GENE's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
ILMNV vs SERA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, SERA has a market cap of 81.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while SERA trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas SERA's P/E ratio is -3.28. In terms of profitability, ILMNV's ROE is N/A, compared to SERA's ROE of -0.41%. Regarding short-term risk, ILMNV is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check SERA's competition here
Atlantic International Corp. (NASDAQ: ATLN)
ILMNV vs ATLN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ATLN's P/E ratio is -0.68. In terms of profitability, ILMNV's ROE is N/A, compared to ATLN's ROE of +14.94%. Regarding short-term risk, ILMNV is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ATLN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
ILMNV vs DRIO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DRIO has a market cap of 51.9M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DRIO trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DRIO's P/E ratio is -1.21. In terms of profitability, ILMNV's ROE is N/A, compared to DRIO's ROE of +0.93%. Regarding short-term risk, ILMNV is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DRIO's competition here
Precipio, Inc. (NASDAQ: PRPO)
ILMNV vs PRPO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PRPO has a market cap of 39.6M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PRPO trades at $22.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PRPO's P/E ratio is -85.12. In terms of profitability, ILMNV's ROE is N/A, compared to PRPO's ROE of -0.07%. Regarding short-term risk, ILMNV is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check PRPO's competition here
Akumin Inc. (NASDAQ: AKU)
ILMNV vs AKU Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas AKU's P/E ratio is -0.13. In terms of profitability, ILMNV's ROE is N/A, compared to AKU's ROE of -5.32%. Regarding short-term risk, ILMNV is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check AKU's competition here
MDxHealth S.A. (NASDAQ: MDXH)
ILMNV vs MDXH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MDXH has a market cap of 23.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MDXH trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MDXH's P/E ratio is -1.20. In terms of profitability, ILMNV's ROE is N/A, compared to MDXH's ROE of +4.03%. Regarding short-term risk, ILMNV is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MDXH's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
ILMNV vs CEMI Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CEMI's P/E ratio is -0.63. In terms of profitability, ILMNV's ROE is N/A, compared to CEMI's ROE of -0.89%. Regarding short-term risk, ILMNV is similarly volatile compared to CEMI. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
ILMNV vs ENZ Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ENZ's P/E ratio is -2.24. In terms of profitability, ILMNV's ROE is N/A, compared to ENZ's ROE of -0.39%. Regarding short-term risk, ILMNV is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ENZ's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
ILMNV vs QUCY Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, QUCY has a market cap of 15.8M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while QUCY trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas QUCY's P/E ratio is -0.06. In terms of profitability, ILMNV's ROE is N/A, compared to QUCY's ROE of -3.26%. Regarding short-term risk, ILMNV is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check QUCY's competition here
Psychemedics Corporation (NASDAQ: PMD)
ILMNV vs PMD Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PMD's P/E ratio is -5.24. In terms of profitability, ILMNV's ROE is N/A, compared to PMD's ROE of -0.32%. Regarding short-term risk, ILMNV is similarly volatile compared to PMD. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
ILMNV vs ME Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ME's P/E ratio is -0.03. In terms of profitability, ILMNV's ROE is N/A, compared to ME's ROE of -42.03%. Regarding short-term risk, ILMNV is similarly volatile compared to ME. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
ILMNV vs MYNZ Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, ILMNV's ROE is N/A, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, ILMNV is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MYNZ's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
ILMNV vs BNGO Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BNGO has a market cap of 12.8M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BNGO trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BNGO's P/E ratio is -0.26. In terms of profitability, ILMNV's ROE is N/A, compared to BNGO's ROE of -0.71%. Regarding short-term risk, ILMNV is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BNGO's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
ILMNV vs CHEK Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CHEK's P/E ratio is -0.43. In terms of profitability, ILMNV's ROE is N/A, compared to CHEK's ROE of -2.26%. Regarding short-term risk, ILMNV is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CHEK's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
ILMNV vs BNR Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BNR has a market cap of 9.5M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BNR trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BNR's P/E ratio is -10.98. In terms of profitability, ILMNV's ROE is N/A, compared to BNR's ROE of -0.11%. Regarding short-term risk, ILMNV is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BNR's competition here
Centogene N.V. (NASDAQ: CNTG)
ILMNV vs CNTG Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CNTG's P/E ratio is -0.23. In terms of profitability, ILMNV's ROE is N/A, compared to CNTG's ROE of +3.98%. Regarding short-term risk, ILMNV is similarly volatile compared to CNTG. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check CNTG's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
ILMNV vs ADVB Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ADVB has a market cap of 8.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ADVB trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ADVB's P/E ratio is -69.18. In terms of profitability, ILMNV's ROE is N/A, compared to ADVB's ROE of -0.21%. Regarding short-term risk, ILMNV is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ADVB's competition here
Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI)
ILMNV vs MBAI Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MBAI has a market cap of 7.9M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MBAI trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MBAI's P/E ratio is 1.69. In terms of profitability, ILMNV's ROE is N/A, compared to MBAI's ROE of +4.17%. Regarding short-term risk, ILMNV is less volatile compared to MBAI. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MBAI's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
ILMNV vs APDN Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas APDN's P/E ratio is -0.10. In terms of profitability, ILMNV's ROE is N/A, compared to APDN's ROE of -6.53%. Regarding short-term risk, ILMNV is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
ILMNV vs NVTA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NVTA's P/E ratio is -0.00. In terms of profitability, ILMNV's ROE is N/A, compared to NVTA's ROE of -2.02%. Regarding short-term risk, ILMNV is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
ILMNV vs LMDXW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, ILMNV's ROE is N/A, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, ILMNV is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
ILMNV vs LMDX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas LMDX's P/E ratio is -0.01. In terms of profitability, ILMNV's ROE is N/A, compared to LMDX's ROE of -15.58%. Regarding short-term risk, ILMNV is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check LMDX's competition here
DermTech, Inc. (NASDAQ: DMTK)
ILMNV vs DMTK Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DMTK's P/E ratio is -0.04. In terms of profitability, ILMNV's ROE is N/A, compared to DMTK's ROE of -1.06%. Regarding short-term risk, ILMNV is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DMTK's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
ILMNV vs NDRA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NDRA has a market cap of 3.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NDRA trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NDRA's P/E ratio is -0.53. In terms of profitability, ILMNV's ROE is N/A, compared to NDRA's ROE of -5.13%. Regarding short-term risk, ILMNV is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NDRA's competition here
Inotiv, Inc. (NASDAQ: NOTV)
ILMNV vs NOTV Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NOTV's P/E ratio is -0.03. In terms of profitability, ILMNV's ROE is N/A, compared to NOTV's ROE of -0.75%. Regarding short-term risk, ILMNV is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NOTV's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
ILMNV vs BIAF Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BIAF has a market cap of 2.7M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BIAF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BIAF's P/E ratio is -0.07. In terms of profitability, ILMNV's ROE is N/A, compared to BIAF's ROE of -3.59%. Regarding short-term risk, ILMNV is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
ILMNV vs SQL Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas SQL's P/E ratio is -0.40. In terms of profitability, ILMNV's ROE is N/A, compared to SQL's ROE of +38.02%. Regarding short-term risk, ILMNV is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
ILMNV vs AWH Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas AWH's P/E ratio is -0.09. In terms of profitability, ILMNV's ROE is N/A, compared to AWH's ROE of +2.03%. Regarding short-term risk, ILMNV is similarly volatile compared to AWH. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check AWH's competition here
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
ILMNV vs INBS Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, INBS has a market cap of 1.2M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while INBS trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas INBS's P/E ratio is -0.21. In terms of profitability, ILMNV's ROE is N/A, compared to INBS's ROE of -1.74%. Regarding short-term risk, ILMNV is less volatile compared to INBS. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check INBS's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
ILMNV vs HTGM Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas HTGM's P/E ratio is -0.03. In terms of profitability, ILMNV's ROE is N/A, compared to HTGM's ROE of -2.73%. Regarding short-term risk, ILMNV is similarly volatile compared to HTGM. This indicates similar risk in terms of short-term price fluctuations for ILMNV.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
ILMNV vs BIOC Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BIOC's P/E ratio is -0.01. In terms of profitability, ILMNV's ROE is N/A, compared to BIOC's ROE of -1.38%. Regarding short-term risk, ILMNV is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
ILMNV vs ISPC Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, ISPC has a market cap of 279.1K. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while ISPC trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas ISPC's P/E ratio is -0.06. In terms of profitability, ILMNV's ROE is N/A, compared to ISPC's ROE of -5.85%. Regarding short-term risk, ILMNV is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
ILMNV vs SQLLW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, ILMNV's ROE is N/A, compared to SQLLW's ROE of +38.02%. Regarding short-term risk, ILMNV is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check SQLLW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
ILMNV vs CHEKZ Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, ILMNV is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check CHEKZ's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
ILMNV vs NDRAW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas NDRAW's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, ILMNV is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check NDRAW's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
ILMNV vs OCDX Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas OCDX's P/E ratio is -42.28. In terms of profitability, ILMNV's ROE is N/A, compared to OCDX's ROE of +0.18%. Regarding short-term risk, ILMNV is less volatile compared to OCDX. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check OCDX's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
ILMNV vs MEUSW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas MEUSW's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, ILMNV is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
ILMNV vs PRXL Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas PRXL's P/E ratio is 42.97. In terms of profitability, ILMNV's ROE is N/A, compared to PRXL's ROE of +0.17%. Regarding short-term risk, ILMNV is less volatile compared to PRXL. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check PRXL's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
ILMNV vs BNGOW Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas BNGOW's P/E ratio is N/A. In terms of profitability, ILMNV's ROE is N/A, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, ILMNV is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check BNGOW's competition here
Danaher Corporation (NYSE: DHR-PA)
ILMNV vs DHR-PA Comparison August 2026
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMNV stands at 17B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, ILMNV is priced at $107.00 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMNV currently has a P/E ratio of N/A, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, ILMNV's ROE is N/A, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, ILMNV is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for ILMNV.Check DHR-PA's competition here